ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32145-10mM(1mLinDMSO) |
|
1258453-75-6 |
ABX464
|
0 | C16H10ClF3N2O | |
GC32144-1g |
|
526-18-1 |
Osalmid (Oxaphenamide)
|
0 | C13H11NO3 | |
GC32144-500mg |
|
526-18-1 |
Osalmid (Oxaphenamide)
|
0 | C13H11NO3 | |
GC32144-100mg |
|
526-18-1 |
Osalmid (Oxaphenamide)
|
0 | C13H11NO3 | |
GC32144-10mM(1mLinDMSO) |
|
526-18-1 |
Osalmid (Oxaphenamide)
|
0 | C13H11NO3 | |
GC32143-100mg |
|
26016-98-8 |
Fosfomycin calcium (Phosphomycin calcium salt)
|
0 | C3H5CaO4P | |
GC32143-10mM(1mLinWater) |
|
26016-98-8 |
Fosfomycin calcium (Phosphomycin calcium salt)
|
0 | C3H5CaO4P | |
GC32142-1g |
|
148-18-5 |
Ditiocarb sodium (Sodium diethyldithiocarbamate)
|
0 | C5H10NNaS2 | |
GC32142-10mM(1mLinDMSO) |
|
148-18-5 |
Ditiocarb sodium (Sodium diethyldithiocarbamate)
|
0 | C5H10NNaS2 | |
GC32141-25mg |
|
1777807-64-3 |
ZINC03129319
|
0 | C24H14N2O6S2 | |
GC32140-100mg |
|
38579-27-0 |
H-Lys-Trp-Lys-OH
|
0 | C23H36N6O4 | |
GC32140-50mg |
|
38579-27-0 |
H-Lys-Trp-Lys-OH
|
0 | C23H36N6O4 | |
GC32140-10mM(1mLinWater) |
|
38579-27-0 |
H-Lys-Trp-Lys-OH
|
0 | C23H36N6O4 | |
GC32139-100mg |
|
113981-44-5 |
Cefozopran hydrochloride (SCE-2787 hydrochloride)
|
0 | C19H18ClN9O5S2 | |
GC32139-50mg |
|
113981-44-5 |
Cefozopran hydrochloride (SCE-2787 hydrochloride)
|
0 | C19H18ClN9O5S2 | |
GC32139-10mM(1mLinWater) |
|
113981-44-5 |
Cefozopran hydrochloride (SCE-2787 hydrochloride)
|
0 | C19H18ClN9O5S2 | |
GC32138-1g |
|
67-45-8 |
Furazolidone
|
0 | C8H7N3O5 | |
GC32138-10mM(1mLinDMSO) |
|
67-45-8 |
Furazolidone
|
0 | C8H7N3O5 | |
GC32137-100mg |
|
1266084-51-8 |
Acoziborole (SCYX-7158)
|
0 | C17H14BF4NO3 | |
GC32137-50mg |
|
1266084-51-8 |
Acoziborole (SCYX-7158)
|
0 | C17H14BF4NO3 | |